Pilar Ayora
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Academic BCMA CAR-T (ARI0002h) achieves MRD-negative remission with sBCMA biomarker response in relapsed POEMS syndrome after double ASCT.
Journal: Annals of hematology
Published: March 30, 2026
Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphoma.
Journal: HemaSphere
Published: December 28, 2025
Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report.
Journal: International journal of molecular sciences
Published: July 31, 2025
Efficacy and safety of the academic anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphoma.
Journal: HemaSphere
Published: February 25, 2025
Nursing care for chimeric antigen receptor T cell therapy survivors: A literature review.
Journal: Asia-Pacific journal of oncology nursing
Published: December 28, 2023
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma.
Journal: British journal of haematology
Published: September 05, 2023
A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe.
Journal: Bone marrow transplantation
Published: August 23, 2019
Home management of acute medical complications in cancer patients: a prospective pilot study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 29, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026